Relative bioavailability of coenzyme Q10 formulations in human subjects

Area of Science:

• Nutritional Science
• Pharmacokinetics
• Biochemistry

Background:

• Coenzyme Q10 (CoQ10) is vital for cellular energy production and antioxidant defense.
• Bioavailability of oral CoQ10 supplements varies significantly, impacting therapeutic efficacy.
• Developing enhanced delivery systems for CoQ10 is crucial for optimizing its absorption and utilization.

Purpose of the Study:

• To compare the relative bioavailability of a novel solubilized CoQ10 formulation (Q-Gel) against conventional CoQ10 products.
• To evaluate the efficacy of Q-Gel in achieving and maintaining adequate plasma CoQ10 concentrations in human subjects.
• To determine if Q-Gel offers superior absorption compared to standard softgel, hardshell capsule, and tablet formulations.

Main Methods:

• Two human clinical trials were conducted to assess CoQ10 bioavailability.
• Participants received daily doses of 120 mg of various CoQ10 forms (standard softgels, powder-filled capsules, tablets, and Q-Gel) for three or four weeks.
• Plasma CoQ10 levels and Area Under the Curve (AUC) were measured to quantify absorption and relative bioavailability.

Main Results:

• Q-Gel showed significantly higher plasma CoQ10 levels compared to all tested conventional forms.
• Relative bioavailability of Q-Gel was 319% in the first trial and 273% in the second trial compared to standard softgels.
• Consistent and superior absorption of Q-Gel was observed across both trials, with lower baseline values and higher post-treatment levels.

Conclusions:

• The solubilized Q-Gel formulation exhibits vastly superior bioavailability over typical commercial CoQ10 preparations.
• Lower doses of Q-Gel are likely sufficient to rapidly achieve and sustain therapeutic plasma CoQ10 concentrations.
• Q-Gel represents a promising advancement in CoQ10 supplementation for enhanced efficacy.